Fig. 1 · Structure
Documents & Downloads
CP-96021
LTD4/PAF Receptor Antagonist
CP-96021 is a potent antagonist of the leukotriene D4 (LTD4) receptor (Ki = 34 μM) and the platelet activating factor (PAF) receptor (Ki = 37 μM). This compound effectively targets two key inflammatory mediators, making it valuable in research on inflammation-related pathologies. With a high specificity profile, CP-96021 demonstrates negligible activity against various receptors, including dopamine, adenosine, and GABA receptors, suggesting minimal off-target effects. This reagent can be employed in studies investigating the pathogenesis of inflammatory diseases, such as asthma.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 139401-43-7 |
| Applications | LTD4/PAF Receptor Antagonist |
| Formula | C29H21FN4OS |
| Molecular Weight | 492.57 |
| SMILES | CC1=NC2=CN=CC=C2N1C3=CC=C(C=C3)OCC4=CC(/C=C/C5=NC6=CC(F)=CC=C6S5)=CC=C4 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.